Buch MH - Search Results

1

The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug.

Navarro Coy NC, Brown S, Bosworth A, Davies CT, Emery P, Everett CC, Fernandez C, Gray JC, Hartley S, Hulme C, Keenan AM, McCabe C, Redmond A, Reynolds C, Scott D, Sharples LD, Pavitt S, Buch MH. Navarro Coy NC, et al. Among authors: buch mh. BMC Musculoskelet Disord. 2014 Dec 23;15:452. doi: 10.1186/1471-2474-15-452. BMC Musculoskelet Disord. 2014. PMID: 25539805 Free PMC article. Clinical Trial.

2

Treating rheumatoid arthritis with tumour necrosis factor alpha blockade.

Emery P, Buch M. Emery P, et al. BMJ. 2002 Feb 9;324(7333):312-3. doi: 10.1136/bmj.324.7333.312. BMJ. 2002. PMID: 11834544 Free PMC article. No abstract available.

3

Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis.

Ponchel F, Morgan AW, Bingham SJ, Quinn M, Buch M, Verburg RJ, Henwood J, Douglas SH, Masurel A, Conaghan P, Gesinde M, Taylor J, Markham AF, Emery P, van Laar JM, Isaacs JD. Ponchel F, et al. Blood. 2002 Dec 15;100(13):4550-6. doi: 10.1182/blood-2002-03-0671. Epub 2002 Aug 8. Blood. 2002. PMID: 12393721 Free article.

4

Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series.

Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, Emery P. Jarrett SJ, et al. Among authors: buch mh. J Rheumatol. 2003 Oct;30(10):2287-91. J Rheumatol. 2003. PMID: 14528531

5

The impact of escalating conventional therapy in rheumatoid arthritis patients referred for anti-tumour necrosis factor-alpha therapy.

Bingham SJ, Buch MH, Tennant A, Emery P. Bingham SJ, et al. Among authors: buch mh. Rheumatology (Oxford). 2004 Mar;43(3):364-8. doi: 10.1093/rheumatology/keh057. Epub 2003 Dec 1. Rheumatology (Oxford). 2004. PMID: 14657509

6

Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals.

Buch MH, Marzo-Ortega H, Bingham SJ, Emery P. Buch MH, et al. Rheumatology (Oxford). 2004 Feb;43(2):243-4. doi: 10.1093/rheumatology/keg454. Rheumatology (Oxford). 2004. PMID: 14739466 No abstract available.

7

Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade.

Buch MH, Bingham SJ, Seto Y, McGonagle D, Bejarano V, White J, Emery P. Buch MH, et al. Arthritis Rheum. 2004 Mar;50(3):725-8. doi: 10.1002/art.20115. Arthritis Rheum. 2004. PMID: 15022311 Free article.

8

True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha?

Buch MH, Conaghan PG, Quinn MA, Bingham SJ, Veale D, Emery P. Buch MH, et al. Ann Rheum Dis. 2004 Oct;63(10):1344-6. doi: 10.1136/ard.2003.014878. Epub 2004 Mar 19. Ann Rheum Dis. 2004. PMID: 15033655 Free PMC article.

9

Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide.

Bingham SJ, Buch MH, Kerr MA, Emery P, Valadäo Barcelos AT. Bingham SJ, et al. Among authors: buch mh. Arthritis Rheum. 2004 Dec;50(12):4072-3. doi: 10.1002/art.20617. Arthritis Rheum. 2004. PMID: 15593202 Free article. No abstract available.

10

C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept.

Buch MH, Seto Y, Bingham SJ, Bejarano V, Bryer D, White J, Emery P. Buch MH, et al. Arthritis Rheum. 2005 Jan;52(1):42-8. doi: 10.1002/art.20711. Arthritis Rheum. 2005. PMID: 15641046 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters